Differential Effect of Ivermectin on Intestinal Helminths in Multimmate Mouse (Mastomys natalensis) Authors: Claus Thomas, Venance Msoffe, Gilbert Mwamengele, Stella Kessy, Emmanuel Hape, Godfrey Katusi, Christopher Sabuni, Isaac Makundi, Herwig Leirs, Robert Machang'u Published: 2026 ABSTRACT ABSTRACT Mastomys natalensis is a widespread rodent species in sub‐Saharan Africa and is increasingly recognised as an important component of food systems in some communities. However, rodents may harbour gastrointestinal helminths with potential implications for animal health, food safety, and zoonotic disease transmission. Information on gastrointestinal helminth infections in M. natalensis and the response of these parasites to anthelmintic treatment is limited. This study investigated the prevalence and diversity of gastrointestinal helminths in M. natalensis and evaluated changes in helminth egg burden following treatment with Ivermectin.A total of 90 adult M. natalensis, comprising 43 males and 47 females, were captured, and their faecal samples were examined for gastrointestinal helminth eggs. Identified helminths were characterised and their prevalence was estimated with 95% confidence intervals. Following baseline assessment, the rodents were allocated to ‐treated and untreated control groups. Faecal egg counts, expressed as eggs per gram of faecal sample (EPG), were monitored every 14 days over an eight‐week period. The change in egg burden was assessed using faecal egg count reduction (FECR).Five gastrointestinal helminth taxa were identified, of which Hymenolepis diminuta was the most prevalent (39%; 95% CI: 29.6–49.3%), followed by Physaloptera spp. (29%; 95% CI: 20.6–39.1%), Rodentolepis nana (12%; 95% CI: 6.8–20.3%), Strongyloides spp. (11%; 95% CI: 6.1–19.1%), and Trichuris spp. (9%; 95% CI: 4.6–16.7%). In the Ivermectin‐treated rodents, mean EPG declined substantially across all five helminth taxa between baseline and weeks post‐treatment. The highest egg reductions were observed for H. diminuta (96.4%) and Trichuris spp. (96.2%), followed by Strongyloides spp. (90.9%), Physaloptera spp. (85.5%), and R. nana (80.0%). The untreated control group showed comparatively little change in overall helminth egg burden. Sex‐specific analyses showed substantial reductions in both males and females over the same period, except for, R. nana females, where egg counts showed an increase. These findings indicate the potential value of Ivermectin in reducing gastrointestinal helminth egg shedding by M. natalensis. Further studies with larger sample sizes, over a longer period, and appropriate experimental replication are warranted to validate treatment with the anthelminth and its implications for animal health, food safety, and potential zoonotic transmission.Keywords: anthelminths, helminths, Ivermectin, Mastomys natalensis Introduction Rodents are recognised reservoirs of helminths of public health concern such as echinococcosis, taeniasis, trichinosis, schistosomiasis, filariasis, and opisthorchiasis (Malsawmtluangi and Tandon, 2009; Meerburg et al., 2009; Stojcevic et al., 2012; Msoffe et al., 2025). Although often classified as neglected tropical diseases owing to their typically mild clinical presentation (Vanden Broecke et al., 2021), helminthic infections can cause chronic and, in immunocompromised individuals, potentially life‐threatening hyperinfection syndrome (Herbreteau et al., 2012; Chaisiri et al., 2017). Globally, an estimated two billion people are infected with parasitic worms, with over one billion cases affecting sub‐Saharan Africa, underscoring the scale of the public health burden in this region (World Health Organization, 2017; Malsawmtluangi and Tandon, 2009; Mulungu et al., 2011; Vanden Broecke et al., 2021). Gastrointestinal helminth surveys of rodents have identified a broad range of taxa, commonly including Strongyloides spp., Hymenolepis diminuta, Rodentolepis nana (formerly classified as Hymenolepis nana), Physaloptera spp., Syphacia spp., and Trichuris spp., with prevalence exceeding 50% in some populations with impact on rodent morbidity and mortality (Malsawmtluangi & Tandon, 2009; Mulungu et al., 2011; Herbreteau et al., 2012; Chaisiri et al., 2017; Paul et al., 2016; Vanden Broecke et al., 2021; Msoffe et al., 2025). Mastomys natalensis, commonly known as the multimammate mouse, is one of the most widespread and ecologically successful rodent species in sub‐Saharan Africa, and is a recognised reservoir of multiple gastrointestinal helminths (Makundi et al., 2007; Mariën et al., 2022; Mlyashimbi et al., 2020; Msoffe et al. 2025). Being a peridomestic species that frequently comes into close contact with humans and livestock, M. natalensis plays an important role in helminth maintenance and transmission across susceptible species (Thomas et al., 2023). In several African regions, M. natalensis and other wild rodents are consumed by people as a subsistence food source, particularly during periods of food scarcity (Bonwitt et al. 2016), and handling is widely regarded as one of the risks for zoonotic pathogen transmission (Meerburg et al. 2009). Despite its epidemiological importance, data on effective anthelmintic treatment options for M. natalensis is scarce. Ivermectin, a broad‐spectrum antiparasitic agent widely used in humans, livestock, and laboratory animals against gastrointestinal nematodes and ectoparasites (Wolstenholme and Rogers, 2005). This drug paralyses and kills susceptible parasites by disrupting glutamate‐ and GABA‐gated chloride channels in invertebrate neuromuscular tissue (Foletto et al., 2015; Cullin et al., 2017; Bosco et al., 2020). Despite the well‐established mechanism and broad use of Ivermectin, its field efficacy in wild small mammals such as M. natalensis has not been thoroughly assessed. This gap is particularly pressing given growing concerns over anthelmintic resistance, side effects, and treatment costs, which make rigorous evaluation increasingly important (Shalaby 2013; Peña‐Espinoza, 2018; Nixon et al., 2020). This study, therefore, aimed to (i) determine the prevalence and diversity of gastrointestinal helminths in M. natalensis, (ii) evaluate changes in helminth egg burden upon Ivermectin treatment, and (iii) examine helminth distribution by host sex. The findings are intended to improve understanding of the role of M. natalensis in zoonotic helminth transmission and to inform future strategies for environmental contamination, control, and rodent‐borne disease management in sub‐Saharan Africa. Materials and Methods Study Area Rodent pre‐sampling was conducted close to the Sokoine University of Agriculture (SUA) ‐Edward Moringe Sokoine Campus‐, Morogoro, Tanzania (6°50′34.9794′′S; 37°38′8.232′′E) (Figure S1, S2), within a one‐hectare rodent‐proof enclosure known as the ‘Fence’, which has previously been used for rodent ecological research. Within the Fence, two separate 0.25‐hectare plots were constructed using rodent‐proof iron sheets for partition. These plots served as independent experimental units for the treatment and control groups in the study (Figure S1). Data Collection Rodent Trapping and Sampling Procedures Free‐ranging rodents were live‐trapped within and outside the enclosed experimental area using Sherman live traps (medium size: 7.6 × 8.9 × 23 cm). Trapping within the experimental plots continued until rodent populations were considered depleted, defined operationally as seven consecutive days without a single capture (King et al. 2011). A total of 300 Sherman traps were deployed during the trapping period. At each site, both inside and outside the Fence, 10 transect lines were established, each transect containing 30 traps spaced at 10‐metre intervals both within and between transects to ensure adequate spatial coverage. A mixture of peanut butter and maize bran was used as bait to attract the rodents. In total, 90 M. natalensis individuals were captured, a sample size deemed adequate, based on similar studies elsewhere (Seras, 2003; Foletto et al., 2015). Each rodent was weighed, and the sex was determined following standard morphological protocols (Maric et al. 2022). Age determination (juvenile or adult) of the captured M. natalensis was based on body size, weight and reproductive status (Henschel et al. 1982; Lalis et al. 2006). Rodent Handling and Faecal Sample Collection The captured rodents were transported to the animal facility at the Institute of Pest Management (IPM), SUA, where they were housed individually in clean cages to allow for the collection of faecal samples (6–10 mm). Each animal was uniquely marked by applying permanent ink to the tail for identification purposes. Food and water were provided ad libitum throughout the holding period. Fresh faecal samples were collected directly from each rodent for the primary screening of helminth eggs. Where spontaneous defecation did not occur, gentle manual stimulation was used to encourage defecation. Collected samples were weighed and immediately preserved in 1.5 mL microtubes containing 70% ethanol, then stored at room temperature for further analysis (Pedersen and Antonovics 2013). Experimental Design and Anthelmintic Treatment in M. natalensis A total of 90 M. natalensis were randomly assigned into two groups: a treatment group and a control group, each containing 45 animals. In the treatment group, the rodents received a single subcutaneous injection of 1% Ivermectin (Hebei Veyong Animal Pharmaceutical Co. Ltd, Shijiazhuang, China) using a 1 µL syringe, according to the protocol described by Kanwar and Varshneya (1995). The dosage administered was based on the body mass, with most animals weighing approximately 35 g, corresponding to 0.2 mg/kg body weight. Following treatment, faecal samples were collected every 14 days for secondary screening of helminth eggs (a total four times) between mid‐May and mid‐July 2022, as recommended by Geurden et al. (2022). Rodents in the control group were not treated and were released into a separate fenced plot (Block B). Faecal samples were also collected every 14 days over the same study period for comparative analysis of helminth egg burden. Helminth Egg Screening and Quantification Screening for helminth eggs was performed using the faecal flotation technique, as described by Foletto et al. (2015). Quantitative analysis of faecal egg counts (FECs) was carried out, using a modified McMaster method, at the Department of Veterinary Microbiology, Sokoine University of Agriculture, according to the protocol outlined by Glover et al. (2017). Briefly, about 3 g of faecal pellets were mixed with flotation solution (analytical‐grade sodium chloride; Fecasol, Vetoquinol USA, Fort Worth, TX) in 50 mL tubes, thoroughly triturated to release helminth eggs, and topped up to 45 mL. An aliquot was transferred to a McMaster counting chamber, covered with a coverslip, and left to stand for at least 10 min before examination under a microscope, at 10X and 40X magnification, to identify and quantify helminth eggs, expressed as eggs per gram of faeces (EPG), following established protocols (Dole et al. 2011; Foletto et al. 2015). Treatment effect was interpreted as the faecal egg count reduction (FECR%), calculated as the percentage change in mean eggs per gram (EPG) from baseline to the final sampling session, following the World Association for the Advancement of Veterinary Parasitology (WAAVP) guideline (Kaplan et al. 2023). Prevalence estimates were reported with 95% confidence intervals calculated using the Wilson score method. Confidence intervals for FECR% were derived by the delta method, propagating the standard errors of the pre‐ and post‐treatment means. All calculations were performed in Python (SciPy and NumPy libraries). The egg count trajectories in the treatment and control groups were plotted and compared graphically across all sampling sessions. Ethical Considerations and Animal Welfare This study received ethical approval from the SUA Ethics and Research Review Committee, the Tanzania Wildlife Research Institute (TAWIRI), and the Tanzania Commission for Science and Technology (COSTECH), under permit number 2022‐401‐NA‐2021‐084. All capturing, handling, treatment, and experimental procedures adhered to institutional and national guidelines for the ethical use of animals in research by trained personnel and followed the 3Rs principles (Replacement, Reduction, Refinement) and ARRIVE 2.0 guidelines to minimise animal use, pain, and distress. At the experimental endpoint, all animals were humanely euthanised using an approved method consistent with accepted veterinary guidelines for rodent welfare. Treated animals were therefore not released into the environment following drug administration. Carcasses, residual Ivermectin, contaminated bedding, and other waste materials were disposed of in accordance with SUA biosafety and environmental protection procedures to prevent contamination of the surrounding ecosystem. Results Prevalence and Diversity of Gastrointestinal Helminths in M. natalensis A total of 90 M. natalensis, adult animals, comprising 43 males (47.8%) and 47 females (52.2%), were captured. Five gastrointestinal helminth species were identified through their eggs in faecal samples. Hymenolepis diminuta presented the highest prevalence (39%; 95% CI: 29.6–49.3%), followed by Physaloptera spp. (29%; 95% CI: 20.6–39.1%), Rodentolepis nana (12%; 95% CI: 6.8–20.3%), Strongyloides spp. (11%; 95% CI: 6.1–19.1%), and Trichuris spp. (9%; 95% CI: 4.6–16.7%) (Table 1). TABLE 1Prevalence of gastrointestinal helminths in M. natalensis.SpeciesPrevalence (%)95% Confidence Interval Hymenolepis diminuta 3929.6 – 49.3 Physaloptera spp.2920.6 – 39.1 Rodentolepis nana126.8 – 20.3 Strongyloides spp.116.1 – 19.1 Trichuris spp.94.6 – 16.7 Prevalence of gastrointestinal helminths in M. natalensis. Effect of Ivermectin on Helminth Egg Burden Following treatment with Ivermectin, the effect was evaluated as the faecal egg count reduction (FECR) at week 8. Ivermectin was associated with a substantial descriptive reduction in mean egg counts across all five helminth species (Table 2). The highest reductions were recorded for H. diminuta (96.4%) and Trichuris spp. (96.2%), followed by Strongyloides spp. (90.9%), Physaloptera spp. (85.5%) and R. nana (80.0%) (Table 2). TABLE 2Faecal egg count reduction (FECR%) following treatment with Ivermectin.SpeciesEggs per Gram—Before TreatmentEggs per Gram—Week 8FECR (%) Hymenolepis diminuta 41,800150096.4 Trichuris spp.660025096.2 Strongyloides spp.12,100110090.9 Physaloptera spp.27,600400085.5 Rodentolepis nana 10,000200080.0 Faecal egg count reduction (FECR%) following treatment with Ivermectin. The trajectory of egg output over the 8‐week study period is shown in Figure S3. In the treatment group, mean EPG declined progressively for all five species following Ivermectin administration. In the untreated control group, mean EPG remained comparatively stable across the same period, without a corresponding downward trend in any of the helminth species (Figure S3). When egg counts for all five species were combined, the total helminth burden fell from a mean of 97,900 EPG at baseline to 8150 EPG at week 8 in the treatment group (91.7% overall reduction), while the total burden in the control group changed comparatively little over the same period (36,200 EPG at baseline vs. 37,200 EPG at week 8) (Figure S3). Helminth Burden by Host Sex Before treatment, males carried a higher combined helminth burden than females (64,700 EPG vs. 37,400 EPG across all species). Following treatment, the burden in both sexes declined to a comparable level (8200 EPG in males and 8200 EPG in females), corresponding to an overall FECR of 87.3% in males and 78.1% in females (Table 3). TABLE 3Faecal egg count reduction (FECR %) by host sex, in the treatment group.SpeciesMale—Eggs per Gram Before TreatmentMale—Eggs per Gram Week 8Male Faecal Egg Count Reduction (%)Female—Eggs per Gram Before TreatmentFemale—Eggs per Gram Week 8Female Faecal Egg Count Reduction (%) Physaloptera spp.15,60050096.812,00040096.7 Trichuris spp.400020095.0660010098.5 Hymenolepis diminuta 29,800230092.312,000240080.0 Strongyloides spp.8000200075.04100190053.7 Rodentolepis nana 7300320056.227003400−25.9 Faecal egg count reduction (FECR %) by host sex, in the treatment group. Egg counts declined in both sexes for four of the five species. For R. nana, egg counts declined in males (56.2% reduction) but increased in females (−25.9%). Discussion This study examined the prevalence and diversity of gastrointestinal helminths in M. natalensis and evaluated changes in helminth egg burden following a single subcutaneous dose of Ivermectin, with particular attention to variation between helminth species and host sex. Three main patterns emerged from the findings. First, M. natalensis in the study area hosts a diverse gastrointestinal helminth community, dominated by two cestode taxa and three nematode taxa. Second, Ivermectin treatment was associated with a marked, broad reduction in faecal egg output relative to an untreated control group whose burden remained essentially unchanged. Third, the magnitude of this reduction varied meaningfully by both helminth species and host sex, in ways that point to underlying biological rather than purely pharmacological explanations. Each of these patterns is considered below in relation to the study's three objectives, before turning to methodological considerations and the broader implications of the findings. The identification of five gastrointestinal helminth taxa, Hymenolepis diminuta, Physaloptera spp., Rodentolepis nana, Strongyloides spp., and Trichuris spp., confirms that M. natalensis in the study area supports a diverse helminth community. This is broadly consistent with that reported for this species and for other murid rodents across sub‐Saharan Africa and beyond (Malsawmtluangi and Tandon, 2009; Mulungu et al., 2011; Msoffe et al., 2025; Vanden Broecke et al., 2021). The predominance of H. diminuta (39%) aligns with previous reports identifying this cestode as one of the most commonly detected gastrointestinal helminths in peridomestic and commensal rodents, a pattern that likely reflects its reliance on generalist arthropod intermediate hosts, such as flour beetles and other stored‐grain insects, that are readily available in agricultural and peridomestic settings similar to the study area surrounding SUA (Msoffe et al. 2025; Yang et al. 2017). Comparable rankings, with H. diminuta and Physaloptera spp. Among the most prevalent taxa have also been reported in other rodent populations elsewhere (Milazzo et al. 2010; Stojcevic et al. 2012; Mohtasebi 2020), suggesting that the helminth community structure observed here reflects broader ecological patterns associated with rodent life history and habitat use, rather than a pattern unique to this population. By contrast, the comparatively low prevalence of R. nana (12%) is somewhat unexpected, given that this species possesses a direct life cycle and is capable of autoinfection features generally associated with higher than lower transmission potential in dense rodent populations (Yang et al. 2017). This apparent disparity may reflect differences in population density, sanitation, or microhabitat conditions between the “Fence” enclosure and the free‐ranging populations described in comparable studies, or it may simply reflect genuine regional variation in helminth community composition, which the present data cannot distinguish. Taken together, however, these findings support the first study objective by confirming that M. natalensis hosts a diverse and regionally consistent gastrointestinal helminth community, reinforcing earlier findings that this species is an important reservoir for helminths of animal and public health relevance in Tanzania (Msoffe et al., 2025; Thomas et al., 2023). For the second objective, Ivermectin treatment was associated with a substantial reduction in mean faecal egg counts across all five helminth taxa, with FECR values ranging from 80.0% (R. nana) to 96.4% (H. diminuta), while the untreated control group showed comparatively little change in total helminth burden over the same eight‐week period. The consistency of this reduction across taxa, against the near‐static burden observed in untreated animals, offers descriptive evidence that the decline in egg output in the treatment group is attributable to Ivermectin administration rather than to seasonal or population‐level trends in transmission. This pattern is broadly consistent with the established anthelmintic action of Ivermectin, which disrupts glutamate‐gated and GABA‐gated chloride channels in invertebrate neuromuscular tissue, leading to paralysis and reduced fecundity or death of susceptible parasites (Martin et al., 2021; Wolstenholme and Rogers, 2005). It also aligns with previous reports of Ivermectin reducing helminth burden, including R. nana, in other rodent hosts under experimental conditions (Foletto et al. 2015; Kanwar and Varshneya 1995). It is worth noting, however, that these FECR values derive from an exploratory, group‐level analysis rather than the confirmatory animal‐level model described in the Methods; they are therefore best interpreted as descriptive evidence of a treatment‐associated effect rather than a formally validated, species‐specific efficacy estimate. Within this descriptive framework, the pattern of variation among taxa is, nonetheless, biologically informative. The nematodes Trichuris spp., Strongyloides spp. and Physaloptera spp., showed FECR values of 96.2%, 90.9%, and 85.5%, respectively, which are broadly consistent with Ivermectin's well‐documented efficacy against gastrointestinal nematodes. More striking is the divergence between the two cestode taxa: H. diminuta showed the highest reduction of all species (96.4%), whereas R. nana showed the lowest (80.0%). Both hymenolepidid cestodes, this difference is unlikely to be explained by drug pharmacodynamics alone and more plausibly reflects differences in life‐cycle biology. H. diminuta requires an obligate arthropod intermediate host and therefore cannot complete a full transmission cycle within an individual rodent or, over a short period, within a fenced plot with reduced arthropod contact; once existing worms are cleared, re‐establishment of infection within the 8‐week study window is comparatively unlikely. Rodentolepi nana, in contrast, is capable of completing its life cycle directly within a single host through internal autoinfection, without the need for an intermediate host. This capacity for continuous internal reinfection could partially offset the drug's parasiticidal effect over the study period, producing an apparently lower FECR that reflects ongoing internal transmission as much as reduced drug susceptibility. This interpretation is consistent with the comparatively modest Ivermectin efficacy against R. nana previously reported in rats (Foletto et al. 2015), and it suggests that target‐parasite biology, rather than treatment efficacy alone, may substantially shape apparent FECR outcomes in similar future studies. Interpreted against World Association for the Advancement of Veterinary Parasitology (WAAVP) conventions developed primarily for livestock nematodes, in which FECR values below 95% are conventionally flagged as suggestive of reduced anthelmintic susceptibility (Kaplan et al. 2023; Geurden et al. 2022; Bosco et al. 2020), three of the five taxa in the present study (Strongyloides spp., Physaloptera spp. and R. nana) would fall below this threshold. This framework should, however, be applied with caution because it was developed for livestock hosts and nematode parasites, not for wild rodents or cestodes with autoinfective life cycles, and the present single‐dose design cannot distinguish reduced drug susceptibility from ongoing reinfection or measurement variability. At the aggregate level, the 91.7% reduction in total combined helminth burden in the treatment group, contrasted with an essentially stable burden in the control group (36,200 to 37,200 EPG), reinforces the overall pattern of a strong, treatment‐associated effect and is broadly comparable to reductions in total helminth burden following anthelmintic treatment in other wild rodent hosts (Pedersen and Antonovics 2013). The third objective concerned helminth distribution by host sex. Males carried a significantly higher combined helminth burden than females at baseline (64,700 vs. 37,400 EPG), a pattern consistent with previous reports of sex‐biased parasite burden in wild rodent populations, often attributed to a combination of behavioural factors such as larger home ranges, greater exploratory activity, and reduced self‐grooming and physiological factors that can differentially expose or predispose male hosts to helminth infection (Ferrari et al. 2015; Moore 1986; Kalueff et al. 2016). Following treatment, both sexes converged to a similar absolute burden of approximately 8200 EPG, despite differing overall FECR values of 87.3% in males and 78.1% in females. This convergence is worth highlighting: because percentage reduction is calculated relative to each sex's own baseline, a similar post‐treatment endpoint reached from different starting points will necessarily produce different FECR percentages, even where the underlying drug response is comparable between sexes. The lower FECR in females should not, therefore, be read as evidence of reduced Ivermectin efficacy in females; rather, it more plausibly reflects their lower starting burden. Against this backdrop, the divergent pattern observed for R. nana stands out as the most notable unexpected finding of the study: egg counts declined in males (56.2%) but increased in females (−25.9%). Given R. nana’s capacity for direct autoinfection, one plausible hypothesis‐generating explanation is that sex‐based differences in behaviour or physiology that influence self‐grooming and coprophagic contact (Moore 1986; Kalueff et al. 2016) could differentially affect the degree of internal reinfection following treatment, effectively masking or reversing the apparent drug effect in one sex. This explanation remains speculative, however, and should be treated as a hypothesis for targeted future investigation rather than as an established finding, given the very small number of animals contributing to this specific sex‐by‐species stratum. Several methodological considerations warrant emphasis in interpreting these findings. Helminth identification relied on egg morphology. Much as it was performed by experienced personnel using standardised protocols, this approach cannot fully exclude cryptic species‐level diversity, particularly among nematodes such as Trichuris, for which morphologically similar but genetically distinct species have been documented in rodent hosts (Ribas et al. 2020). In addition, because both cestode taxa are subject to ongoing reinfection dynamics that a single 8‐week observation window cannot fully resolve, longer‐term or repeated‐dosing designs would be needed to distinguish true differences in drug susceptibility from the influence of continued transmission. Together with the exploratory, group‐level nature of the statistical analysis described above, these considerations indicate that the present findings should be regarded as an informative descriptive baseline rather than a definitive efficacy assessment, pending the confirmatory animal‐level analysis outlined in the Methods. Taken as a whole, these findings provide descriptive evidence that a single dose of Ivermectin can produce a substantial, broad reduction in gastrointestinal helminth egg output in M. natalensis under field‐enclosure conditions, with the degree of reduction varying by parasite species in ways that appear, at least partly, attributable to differences in life‐cycle biology rather than to drug action alone. Given that M. natalensis is a peridomestic reservoir of zoonotic helminths and, in some communities a source of food, interventions that reduce helminth egg shedding in this species could have relevance for environmental contamination control and for reducing potential zoonotic and food‐safety risk at the human–rodent interface. Confirming this potential, however, will require the planned animal‐level statistical analysis, replication across sites and seasons, as well as evaluation of repeated‐dose or longer‐follow‐up regimens — particularly for helminth taxa such as R. nana that are capable of autoinfection. Author Contributions C. T. conceived the study, coordinated fieldwork, performed laboratory analyses, and wrote the manuscript. V. M., G. M., S. K. and E. H. assisted with study design, data interpretation and manuscript editing. G, K., C. S. and I. M. supported conceptualization, experimental setup, manuscript review and methodology. H. L. and R. M. contributed to methodology development, data analysis guidance, and manuscript review. All authors read and approved the final manuscript. Funding This work was financially supported by the Research Foundation‐Flanders (FWO) (LA1100135) and the African Centre of Excellence for Innovative Rodent Pest Management and Biosensor Technology Development (ACE IRPM & BTD) ACE II‐Credit number 5799–TZ of the Sokoine University of Agriculture, Morogoro, Tanzania. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File 1: Location of Fence’ close to SUA main campus Supporting File 2: Mean eggs per gram (EPG ± SE) over the 8‐week study period, treatment (Ivermectin) versus control (untreated) groups, by helminth species. Supporting File 3: Total mean helminth egg burden (all five species combined) over the 8‐week study period, treatment versus control group. Acknowledgements The authors would like to thank the SUA staff, SFUCHAS staff, IHI scientists (molecular biology division), staff of the UA‐Evolutionary Ecology Group, SUA, the Institute of Pest Management (IPM) field units and regional administrators of Morogoro for their support and cooperation during the study. Data Availability Statement Data can be obtained from the corresponding author upon a request. References Associated Data Supplementary Materials Supporting File 1: Location of Fence’ close to SUA main campus Supporting File 2: Mean eggs per gram (EPG ± SE) over the 8‐week study period, treatment (Ivermectin) versus control (untreated) groups, by helminth species. Supporting File 3: Total mean helminth egg burden (all five species combined) over the 8‐week study period, treatment versus control group. Data Availability Statement Data can be obtained from the corresponding author upon a request.